Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2019

Nov 06, 2019

SELL
$106.79 - $116.16 $11.7 Million - $12.7 Million
-109,300 Closed
0 $0
Q2 2019

Aug 02, 2019

BUY
$110.79 - $129.32 $12.1 Million - $14.1 Million
109,300 New
109,300 $12.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Broad Peak Investment Holdings Ltd. Portfolio

Follow Broad Peak Investment Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broad Peak Investment Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Broad Peak Investment Holdings Ltd. with notifications on news.